| 2 型糖尿病与结直肠癌关系的临床研究* |
| |
| 引用本文： | 滕家安,秦俭,梁远,王仁生,汤春园. 2 型糖尿病与结直肠癌关系的临床研究*[J]. 中国肿瘤临床, 2010, 37(3): 152-155. DOI: 10.3969/j.issn.1000-8179.2010.03.009 |
| |
| 作者姓名： | 滕家安 秦俭 梁远 王仁生 汤春园 |
| |
| 作者单位： | 广西壮族自治区人民医院内分泌代谢科(南宁市530021 )① 肿瘤放疗科 ② 广西壮族自治区卫生厅 ③ 广西医科大学第一附属医院放疗科 |
| |
| 基金项目： | 本文课题受广西壮族自治区卫生厅科研基金资助 |
| |
| 摘 要： | 目的:探讨2 型糖尿病（T2DM）与结直肠癌发病和转移的关系。方法:收集广西医科大学第一附属医院2001年1 月至2006年12月间收治的结直肠癌患者852 例和非肿瘤患者940 例的临床资料。比较两组在性别、肿瘤部位、糖尿病病程和肝转移等方面的差异，并对相关危险因素进行分析。结果:T2DM患者结直肠癌发病的危险显著高于非T2DM 患者，其OR值为2.466，男性T2DM 患者发生结直肠癌的危险高于女性，差异无统计学意义（OR值2.775 vs 2.070，P=0.394）。 患有左半结肠癌的患者发生T2DM的比例最高，但与患有右半结肠癌和直肠癌者无显著性差异。T2DM病程在10～20年组发生结直肠癌的危险性最高，其OR值为4.696。T2DM合并结直肠癌患者发生肝脏转移危险性高于非T2DM合并结直肠癌患者，其OR值为2.888。结论:T2DM可能是结直肠癌发生的危险因素之一，在T2DM病程小于20年以内这种危险性随着病程的增加而增加；T2DM合并结直肠癌患者更容易发生肝脏转移。
|
| 关 键 词： | 2 型糖尿病 结直肠癌 临床研究 |
| 收稿时间： | 2009-03-25 |
Clinical Research on the Relationship between Type 2 Diabetes Mellitus and Colorectal Cancer |
| |
| TENG Jiaan,QIN Jian,LIANG Yuan,WANG Rensheng,TANG Chunyuan. Clinical Research on the Relationship between Type 2 Diabetes Mellitus and Colorectal Cancer[J]. Chinese Journal of Clinical Oncology, 2010, 37(3): 152-155. DOI: 10.3969/j.issn.1000-8179.2010.03.009 |
| |
| Authors: | TENG Jiaan QIN Jian LIANG Yuan WANG Rensheng TANG Chunyuan |
| |
| Affiliation: | 1Department of Endocriology & Metabolism, People ’s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China |
| |
| Abstract: | Objective: To investigate the relationship between type 2 diabetes mellitus (T2DM) and the pathogenesis and metastasis of colorectal cancer. Methods: A case-control study was performed to compare 852 colorectal cancer patients with 940 controls (patients without cancer) recruited from 2001 to 2006, with respect to their sex, cancer subsite, the course of T2DM, hepatic metastasis, smoking and drinking. Correlated risk factors were analyzed. Results: The risk of colorectal cancer was increased in patients with T2DM and the relative risk (OR) was 2.466. The OR of male patients was higher than that of female patients, but with no significant difference (2.775 vs 2.070, P=0.394). The incidence of T2DM in patients with left hemicolon cancer was higher than that in those with right hemicolon cancer and rectal cancer, but with no significant difference between them. The colorectal cancer risk in T2DM patients with a DM course of 10 ～ 20 years was the highest, and the OR was 4.696. The rate of hepatic metastasis was higher in T2DM patients with colorectal cancer than that in celorectal cancer patients without T2DM and the OR was 2.888. Conclusion: T2DM may be one of the important pathogenic risk factors for colorectal cancer. The OR is increased with the extension of DM course within 20 years. Colorectal cancer patients with T2DM may be more prone to hepatic metastasis. |
| |
| Keywords: | Type 2 diabetes mellitus Colorectal cancer Clinical study |
| 本文献已被 万方数据 等数据库收录！ |
| 点击此处可从《中国肿瘤临床》浏览原始摘要信息 |
|
点击此处可从《中国肿瘤临床》下载免费的PDF全文 |
|
